Inflammatory Bowel Disease - U.S. Department of Veterans Affairs

The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease.

However, the intrinvasive nature and high cost of endoscopy make it unsuitable for routine monitoring of disease prevalence in IBD patients, and even when imaging can replace endoscopy, high cost remains a concern. This review introduces currently available non-invasive biomarkers of clinical importance in lab testing for IBD, as well as the challenges and challenges in the IBD biomarker studies.

Source link: https://doi.org/10.3390/biomedicines10071492

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions